Link to this page
Medical Subject Headings
| Preferred Name | Sitagliptin Phosphate | |
| Synonyms |
Anhydrous, Sitagliptin Phosphate 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine Sitagliptin Phosphate Monohydrate Phosphate Anhydrous, Sitagliptin Monohydrate, Sitagliptin Phosphate MK 0431 Phosphate, Sitagliptin Phosphate Monohydrate, Sitagliptin Sitagliptin Monohydrate, Sitagliptin Monophosphate Monophosphate Monohydrate, Sitagliptin MK0431 Sitagliptin Phosphate Anhydrous Januvia Sitagliptin Monophosphate Monohydrate MK-0431 0431, MK |
|
| Definitions |
A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000068900 |
|
| altLabel |
Anhydrous, Sitagliptin Phosphate 4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine Sitagliptin Phosphate Monohydrate Phosphate Anhydrous, Sitagliptin Monohydrate, Sitagliptin Phosphate MK 0431 Phosphate, Sitagliptin Phosphate Monohydrate, Sitagliptin Sitagliptin Monohydrate, Sitagliptin Monophosphate Monophosphate Monohydrate, Sitagliptin MK0431 Sitagliptin Phosphate Anhydrous Januvia Sitagliptin Monophosphate Monohydrate MK-0431 0431, MK
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C1702177 C3661346 C1667080 C1565751 C1565750 C5235129
|
|
| DC |
1
|
|
| definition |
A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.
|
|
| DX |
20160101
|
|
| FX |
D000069476
|
|
| HN |
2016 (2005)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
494P4635I6 TS63EW8X6F 0 QFP0P1DV7Z
|
|
| Inverse of RO | ||
| isa |
http://purl.bioontology.org/ontology/MESH/D007004 |
|
| LT |
TRD
|
|
| Machine permutation |
2016; SITAGLIPTIN PHOSPHATE was indexed under PYRAZINES and TRIAZOLES 2005-2015
|
|
| Mapped from | ||
| MDA |
20150709
|
|
| MMR |
20160531
|
|
| MN |
D03.383.679.875 D03.383.129.799.725
|
|
| notation |
D000068900
|
|
| PA |
D054873 D007004 D054795
|
|
| prefLabel |
Sitagliptin Phosphate
|
|
| RR |
486460-32-6 (sitagliptin) 494P4635I6 654671-77-9 (sitagliptin phosphate) QFP0P1DV7Z
|
|
| TERMUI |
T630749 T630747 T000877725 T666530 T000877724 T000877721 T000877722 T000877723 T000877719 T630748
|
|
| TH |
NLM (2016) NLM (2005) FDA SRS (2013) USAN (19XX) INN (19XX) NLM (2013) NLM (2006)
|
|
| tui |
T109 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |